Trial intelligence / Profile preview

Intradermal versus subcutaneous yellow fever vaccination

NL-OMON27364Active, not recruiting

Sponsor
Leiden University Medical Center
Start
Jun 2005
Modality
Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

Open-label trial of 17D yellow fever vaccine in yellow fever (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Protective humoral immune response. Started Jun 2005; status: active, not recruiting.

02

Drugs

17D yellow fever vaccine
03

Conditions

yellow fever

Beyond the preview

Go deeper on NL-OMON27364.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON27364.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call